These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 1820660

  • 21. Yellow nail syndrome.
    Elmariah SB, Ubriani RR, Kovich O.
    Dermatol Online J; 2008 Oct 15; 14(10):17. PubMed ID: 19061616
    [Abstract] [Full Text] [Related]

  • 22. Yellow nail syndrome: treatment with octreotide.
    Hillerdal G.
    Clin Respir J; 2007 Dec 15; 1(2):120-1. PubMed ID: 20298292
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.
    Lehuédé G, Toussirot E, Despaux J, Michel F, Wendling D.
    Joint Bone Spine; 2002 Jun 15; 69(4):406-8. PubMed ID: 12184439
    [Abstract] [Full Text] [Related]

  • 25. [A case of rheumatoid arthritis associated with minimal change nephrotic syndrome].
    Matsubara Y, Nishiya K, Tahara K, Hosokawa T, Hashimoto K, Moriki T, Ota K, Nishimura S.
    Rinsho Byori; 2001 Dec 15; 49(12):1293-7. PubMed ID: 11797400
    [Abstract] [Full Text] [Related]

  • 26. [A case of yellow nail syndrome presenting as recurrent pneumonia].
    Tanoue M, Satoh T, Yoshizawa Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 15; 31(12):1566-71. PubMed ID: 8121094
    [Abstract] [Full Text] [Related]

  • 27. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
    Kishimoto N, Fujii K.
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr 15; 40(4):321-5. PubMed ID: 12096503
    [Abstract] [Full Text] [Related]

  • 28. Patients with rheumatoid arthritis (RA) and proteinuria.
    Urata Y.
    Clin Exp Nephrol; 2004 Sep 15; 8(3):288; author reply 289; discussion 290. PubMed ID: 15480911
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The Development of Yellow Nail Syndrome after the Implantation of a Permanent Cardiac Pacemaker.
    Suzuki T, Tokuda Y, Kobayashi H.
    Intern Med; 2017 Oct 01; 56(19):2667-2669. PubMed ID: 28883248
    [Abstract] [Full Text] [Related]

  • 31. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
    Tunc SE, Ertam I, Pirildar T, Turk T, Ozturk M, Doganavsargil E.
    J Eur Acad Dermatol Venereol; 2007 Apr 01; 21(4):497-503. PubMed ID: 17373977
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Yellow nail syndrome: a perspective.
    Fields CL, Roy TM, Ossorio MA, Mercer PJ.
    J Ky Med Assoc; 1991 Nov 01; 89(11):563-5. PubMed ID: 1748833
    [Abstract] [Full Text] [Related]

  • 34. Nail abnormalities in rheumatoid arthritis.
    Michel C, Cribier B, Sibilia J, Kuntz JL, Grosshans E.
    Br J Dermatol; 1997 Dec 01; 137(6):958-62. PubMed ID: 9470915
    [Abstract] [Full Text] [Related]

  • 35. Comparison of clinical effects of bucillamine between additive combination and single administration study in rheumatoid arthritis.
    Nobunaga M, Yasuda M.
    Agents Actions Suppl; 1993 Dec 01; 44():105-9. PubMed ID: 8372720
    [Abstract] [Full Text] [Related]

  • 36. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
    Kim HA, Song YW.
    Rheumatol Int; 1997 Dec 01; 17(1):5-9. PubMed ID: 9194208
    [Abstract] [Full Text] [Related]

  • 37. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR, Idle JR, Smith RL, Waring RH.
    J Rheumatol; 1984 Oct 01; 11(5):626-32. PubMed ID: 6334741
    [Abstract] [Full Text] [Related]

  • 38. [Analysis of the state of patients with rheumatoid arthritis using a personal computer].
    Hirohata S, Kawashima C, Shinohara S, Sawada T, Nishioka Y, Tohma S, Kisaki T, Inoue T, Iwamoto S, Ito K.
    Ryumachi; 1993 Apr 01; 33(2):131-41. PubMed ID: 8316903
    [Abstract] [Full Text] [Related]

  • 39. [A case of progressive systemic sclerosis with Sjögren's syndrome complicated by nephrotic syndrome caused by bucillamine].
    Ogawa N, Itoh M, Sudo Y, Endo S, Ohashi H, Okugawa T, Furuya R, Hishida A.
    Ryumachi; 1990 Oct 01; 30(5):362-6, 308; discussion 366-8. PubMed ID: 2084858
    [Abstract] [Full Text] [Related]

  • 40. Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.
    Hur JW, Lee CW, Yoo DH.
    J Korean Med Sci; 2006 Jun 01; 21(3):585-7. PubMed ID: 16778412
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.